LIXT
NASDAQ · Biotechnology
Lixte Biotechnology Holdings
$3.33
-0.27 (-7.50%)
Open$3.51
Previous Close$3.60
Day High$3.51
Day Low$3.29
52W High$8.38
52W Low$2.36
Volume—
Avg Volume233.3K
Market Cap125.36M
P/E Ratio—
EPS$-1.10
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.59M | 2.67M | 2.41M |
| Net Income | 404.7K | 492.8K | 436.5K |
| Profit Margin | 15.6% | 18.4% | 18.1% |
| EBITDA | 711.7K | 711.0K | 701.7K |
| Free Cash Flow | 315.8K | 252.8K | 287.8K |
| Rev Growth | +13.7% | +15.1% | +4.1% |
| Debt/Equity | 1.15 | 1.36 | 1.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |